Skip to main content
Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4184
+0.0312 (8.06%)
At close: Nov 13, 2026, 4:00 PM EST
0.4252
+0.0068 (1.63%)
After-hours: Nov 13, 2026, 7:47 PM EST

Ensysce Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.195.075.212.232.523.53
Revenue Growth
37.91%-2.75%133.58%-11.61%-28.54%-10.17%
Gross Profit
-4.19-5.31-2.01-5.36-17.31-1.16
Operating Income
-11.51-10.24-6.73-10.72-24.22-19.87
Net Income
-91.21-10.18-7.99-10.63-25.09-29.89
Earnings Per Share
-8.71-3.98-11.45-70.40-2091.33-
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.674.313.51.123.1512.26
Total Debt
0.150.310.30.854.4317.21
Net Cash (Debt)
29.5243.20.27-1.29-4.95
Net Cash Growth
2196.04%25.10%1090.16%---
Net Cash Per Share
2.821.574.591.78-107.24-

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.39-7.81-7.5-10.78-17.89-8.24
Capital Expenditures
-0.05-0.12----
Free Cash Flow
-8.44-7.93-7.5-10.78-17.89-8.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-67.66%-104.81%-38.57%-240.17%--32.82%
Operating Margin
-185.96%-202.13%-129.18%-480.52%-959.91%-562.71%
Pretax Margin
-1473.73%-200.85%-153.30%-476.40%-959.33%-825.38%
Profit Margin
-1473.72%-200.84%-153.31%-476.39%-994.12%-846.37%
FCF Margin
-136.33%-156.51%-144.00%-483.30%-708.87%-233.41%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.320.662.041.501.9132.28